Sera Prognostics Stock (NASDAQ: SERA) stock price, news, charts, stock research, profile.
Open | $10.280 |
Close | - |
Volume / Avg. | 43.569K / 225.737K |
Day Range | 10.070 - 10.900 |
52 Wk Range | 1.520 - 11.320 |
Market Cap | $348.277M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 0.85% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Sera Prognostics (NASDAQ: SERA) through any online brokerage.
Other companies in Sera Prognostics’s space includes: Skye Bioscience (NASDAQ:SKYE), Precigen (NASDAQ:PGEN), PepGen (NASDAQ:PEPG), Replimune Group (NASDAQ:REPL) and Opthea (NASDAQ:OPT).
The latest price target for Sera Prognostics (NASDAQ: SERA) was reported by Citigroup on Thursday, August 10, 2023. The analyst firm set a price target for 2.75 expecting SERA to fall to within 12 months (a possible -74.23% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Sera Prognostics (NASDAQ: SERA) is $10.67 last updated Today at April 26, 2024 at 2:28 PM EDT.
There are no upcoming dividends for Sera Prognostics.
Sera Prognostics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Sera Prognostics.
Sera Prognostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.